| Product Code: ETC8533004 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Bacteriophages Therapy Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Netherlands Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Netherlands Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Netherlands Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Netherlands Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Netherlands Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections driving the demand for alternative therapies like bacteriophages. |
4.2.2 Growing awareness among healthcare professionals and patients about the benefits of bacteriophage therapy. |
4.2.3 Supportive government initiatives and funding for research and development in the field of bacteriophage therapy. |
4.3 Market Restraints |
4.3.1 Limited clinical evidence and regulatory approval for bacteriophage therapy in the Netherlands. |
4.3.2 Challenges in the production and standardization of bacteriophages for therapeutic use. |
4.3.3 Competition from existing antibiotics and other antimicrobial therapies. |
5 Netherlands Bacteriophages Therapy Market Trends |
6 Netherlands Bacteriophages Therapy Market, By Types |
6.1 Netherlands Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Netherlands Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Netherlands Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Netherlands Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Netherlands Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Netherlands Bacteriophages Therapy Market Export to Major Countries |
7.2 Netherlands Bacteriophages Therapy Market Imports from Major Countries |
8 Netherlands Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted on bacteriophage therapy in the Netherlands. |
8.2 Rate of adoption of bacteriophage therapy by healthcare facilities. |
8.3 Investment in research and development for bacteriophage therapy. |
8.4 Patient outcomes and success rates of bacteriophage therapy. |
8.5 Number of partnerships and collaborations between research institutions and pharmaceutical companies in the field of bacteriophage therapy. |
9 Netherlands Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Netherlands Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Netherlands Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Netherlands Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Netherlands Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Bacteriophages Therapy Market - Competitive Landscape |
10.1 Netherlands Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here